nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC3—Cisplatin—testicular cancer	0.113	0.138	CbGbCtD
Gadoxetate—ABCC3—Etoposide—testicular cancer	0.111	0.136	CbGbCtD
Gadoxetate—ABCC3—Doxorubicin—testicular cancer	0.0755	0.0926	CbGbCtD
Gadoxetate—ABCC3—Methotrexate—testicular cancer	0.0731	0.0897	CbGbCtD
Gadoxetate—SLCO1B3—Methotrexate—testicular cancer	0.0649	0.0796	CbGbCtD
Gadoxetate—ABCC2—Carboplatin—testicular cancer	0.0599	0.0735	CbGbCtD
Gadoxetate—ABCC4—Methotrexate—testicular cancer	0.0559	0.0685	CbGbCtD
Gadoxetate—ABCC2—Vinblastine—testicular cancer	0.0558	0.0685	CbGbCtD
Gadoxetate—ABCC2—Cisplatin—testicular cancer	0.0512	0.0628	CbGbCtD
Gadoxetate—ABCC2—Etoposide—testicular cancer	0.0503	0.0617	CbGbCtD
Gadoxetate—SLCO1B1—Methotrexate—testicular cancer	0.0378	0.0464	CbGbCtD
Gadoxetate—ABCC2—Doxorubicin—testicular cancer	0.0343	0.0421	CbGbCtD
Gadoxetate—ABCC2—Methotrexate—testicular cancer	0.0332	0.0407	CbGbCtD
Gadoxetate—Pruritus—Bleomycin—testicular cancer	0.000217	0.00118	CcSEcCtD
Gadoxetate—Feeling abnormal—Ifosfamide—testicular cancer	0.000216	0.00117	CcSEcCtD
Gadoxetate—Chest pain—Etoposide—testicular cancer	0.000216	0.00117	CcSEcCtD
Gadoxetate—Nausea—Vinblastine—testicular cancer	0.000216	0.00117	CcSEcCtD
Gadoxetate—Anorexia—Cisplatin—testicular cancer	0.000215	0.00117	CcSEcCtD
Gadoxetate—Hypokalaemia—Epirubicin—testicular cancer	0.000215	0.00116	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000214	0.00116	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000214	0.00116	CcSEcCtD
Gadoxetate—Discomfort—Etoposide—testicular cancer	0.000213	0.00116	CcSEcCtD
Gadoxetate—Hypotension—Cisplatin—testicular cancer	0.000211	0.00114	CcSEcCtD
Gadoxetate—Face oedema—Doxorubicin—testicular cancer	0.000211	0.00114	CcSEcCtD
Gadoxetate—Hypersensitivity—Dactinomycin—testicular cancer	0.000211	0.00114	CcSEcCtD
Gadoxetate—Urticaria—Ifosfamide—testicular cancer	0.000208	0.00113	CcSEcCtD
Gadoxetate—Abdominal pain—Ifosfamide—testicular cancer	0.000207	0.00112	CcSEcCtD
Gadoxetate—Body temperature increased—Ifosfamide—testicular cancer	0.000207	0.00112	CcSEcCtD
Gadoxetate—Anaphylactic shock—Etoposide—testicular cancer	0.000207	0.00112	CcSEcCtD
Gadoxetate—Infection—Etoposide—testicular cancer	0.000206	0.00111	CcSEcCtD
Gadoxetate—Abdominal distension—Epirubicin—testicular cancer	0.000205	0.00111	CcSEcCtD
Gadoxetate—Asthenia—Dactinomycin—testicular cancer	0.000205	0.00111	CcSEcCtD
Gadoxetate—Blood creatinine increased—Doxorubicin—testicular cancer	0.000205	0.00111	CcSEcCtD
Gadoxetate—Dysphagia—Epirubicin—testicular cancer	0.000204	0.00111	CcSEcCtD
Gadoxetate—Dehydration—Doxorubicin—testicular cancer	0.000203	0.0011	CcSEcCtD
Gadoxetate—Paraesthesia—Cisplatin—testicular cancer	0.000203	0.0011	CcSEcCtD
Gadoxetate—Tachycardia—Etoposide—testicular cancer	0.000202	0.0011	CcSEcCtD
Gadoxetate—Dyspnoea—Cisplatin—testicular cancer	0.000201	0.00109	CcSEcCtD
Gadoxetate—Skin disorder—Etoposide—testicular cancer	0.000201	0.00109	CcSEcCtD
Gadoxetate—Hyperhidrosis—Etoposide—testicular cancer	0.0002	0.00108	CcSEcCtD
Gadoxetate—Hypokalaemia—Doxorubicin—testicular cancer	0.000199	0.00108	CcSEcCtD
Gadoxetate—Anorexia—Etoposide—testicular cancer	0.000197	0.00107	CcSEcCtD
Gadoxetate—Decreased appetite—Cisplatin—testicular cancer	0.000196	0.00106	CcSEcCtD
Gadoxetate—Bronchitis—Epirubicin—testicular cancer	0.000196	0.00106	CcSEcCtD
Gadoxetate—Diarrhoea—Dactinomycin—testicular cancer	0.000196	0.00106	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000195	0.00106	CcSEcCtD
Gadoxetate—Vomiting—Bleomycin—testicular cancer	0.000195	0.00106	CcSEcCtD
Gadoxetate—Hypotension—Etoposide—testicular cancer	0.000193	0.00105	CcSEcCtD
Gadoxetate—Rash—Bleomycin—testicular cancer	0.000193	0.00105	CcSEcCtD
Gadoxetate—Dermatitis—Bleomycin—testicular cancer	0.000193	0.00105	CcSEcCtD
Gadoxetate—Hypersensitivity—Ifosfamide—testicular cancer	0.000193	0.00105	CcSEcCtD
Gadoxetate—Renal failure—Methotrexate—testicular cancer	0.000191	0.00104	CcSEcCtD
Gadoxetate—Abdominal distension—Doxorubicin—testicular cancer	0.00019	0.00103	CcSEcCtD
Gadoxetate—Conjunctivitis—Methotrexate—testicular cancer	0.000189	0.00102	CcSEcCtD
Gadoxetate—Dysphagia—Doxorubicin—testicular cancer	0.000189	0.00102	CcSEcCtD
Gadoxetate—Asthenia—Ifosfamide—testicular cancer	0.000188	0.00102	CcSEcCtD
Gadoxetate—Feeling abnormal—Cisplatin—testicular cancer	0.000186	0.00101	CcSEcCtD
Gadoxetate—Paraesthesia—Etoposide—testicular cancer	0.000186	0.00101	CcSEcCtD
Gadoxetate—Pruritus—Ifosfamide—testicular cancer	0.000185	0.00101	CcSEcCtD
Gadoxetate—Dyspnoea—Etoposide—testicular cancer	0.000184	0.001	CcSEcCtD
Gadoxetate—Nausea—Bleomycin—testicular cancer	0.000182	0.000988	CcSEcCtD
Gadoxetate—Vomiting—Dactinomycin—testicular cancer	0.000182	0.000986	CcSEcCtD
Gadoxetate—Bronchitis—Doxorubicin—testicular cancer	0.000181	0.000984	CcSEcCtD
Gadoxetate—Rash—Dactinomycin—testicular cancer	0.00018	0.000978	CcSEcCtD
Gadoxetate—Decreased appetite—Etoposide—testicular cancer	0.00018	0.000976	CcSEcCtD
Gadoxetate—Diarrhoea—Ifosfamide—testicular cancer	0.000179	0.000972	CcSEcCtD
Gadoxetate—Renal failure—Epirubicin—testicular cancer	0.000179	0.00097	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Etoposide—testicular cancer	0.000179	0.000969	CcSEcCtD
Gadoxetate—Body temperature increased—Cisplatin—testicular cancer	0.000179	0.000968	CcSEcCtD
Gadoxetate—Fatigue—Etoposide—testicular cancer	0.000178	0.000968	CcSEcCtD
Gadoxetate—Constipation—Etoposide—testicular cancer	0.000177	0.00096	CcSEcCtD
Gadoxetate—Conjunctivitis—Epirubicin—testicular cancer	0.000177	0.000959	CcSEcCtD
Gadoxetate—Dizziness—Ifosfamide—testicular cancer	0.000173	0.00094	CcSEcCtD
Gadoxetate—Feeling abnormal—Etoposide—testicular cancer	0.00017	0.000925	CcSEcCtD
Gadoxetate—Nausea—Dactinomycin—testicular cancer	0.00017	0.000921	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Etoposide—testicular cancer	0.000169	0.000918	CcSEcCtD
Gadoxetate—Vomiting—Ifosfamide—testicular cancer	0.000167	0.000903	CcSEcCtD
Gadoxetate—Hypersensitivity—Cisplatin—testicular cancer	0.000166	0.000902	CcSEcCtD
Gadoxetate—Renal failure—Doxorubicin—testicular cancer	0.000165	0.000897	CcSEcCtD
Gadoxetate—Rash—Ifosfamide—testicular cancer	0.000165	0.000896	CcSEcCtD
Gadoxetate—Dermatitis—Ifosfamide—testicular cancer	0.000165	0.000895	CcSEcCtD
Gadoxetate—Urticaria—Etoposide—testicular cancer	0.000164	0.000891	CcSEcCtD
Gadoxetate—Rhinitis—Epirubicin—testicular cancer	0.000164	0.000888	CcSEcCtD
Gadoxetate—Abdominal pain—Etoposide—testicular cancer	0.000164	0.000887	CcSEcCtD
Gadoxetate—Body temperature increased—Etoposide—testicular cancer	0.000164	0.000887	CcSEcCtD
Gadoxetate—Conjunctivitis—Doxorubicin—testicular cancer	0.000164	0.000887	CcSEcCtD
Gadoxetate—Hypoaesthesia—Epirubicin—testicular cancer	0.000162	0.000881	CcSEcCtD
Gadoxetate—Asthenia—Cisplatin—testicular cancer	0.000162	0.000879	CcSEcCtD
Gadoxetate—Cardiac disorder—Methotrexate—testicular cancer	0.000162	0.000878	CcSEcCtD
Gadoxetate—Connective tissue disorder—Epirubicin—testicular cancer	0.00016	0.00087	CcSEcCtD
Gadoxetate—Angiopathy—Methotrexate—testicular cancer	0.000158	0.000858	CcSEcCtD
Gadoxetate—Immune system disorder—Methotrexate—testicular cancer	0.000158	0.000855	CcSEcCtD
Gadoxetate—Mediastinal disorder—Methotrexate—testicular cancer	0.000157	0.000853	CcSEcCtD
Gadoxetate—Chills—Methotrexate—testicular cancer	0.000156	0.000849	CcSEcCtD
Gadoxetate—Nausea—Ifosfamide—testicular cancer	0.000156	0.000844	CcSEcCtD
Gadoxetate—Diarrhoea—Cisplatin—testicular cancer	0.000154	0.000838	CcSEcCtD
Gadoxetate—Hypersensitivity—Etoposide—testicular cancer	0.000152	0.000827	CcSEcCtD
Gadoxetate—Cardiac disorder—Epirubicin—testicular cancer	0.000151	0.000822	CcSEcCtD
Gadoxetate—Flushing—Epirubicin—testicular cancer	0.000151	0.000822	CcSEcCtD
Gadoxetate—Rhinitis—Doxorubicin—testicular cancer	0.000151	0.000821	CcSEcCtD
Gadoxetate—Hypoaesthesia—Doxorubicin—testicular cancer	0.00015	0.000815	CcSEcCtD
Gadoxetate—Dysgeusia—Methotrexate—testicular cancer	0.000149	0.000807	CcSEcCtD
Gadoxetate—Asthenia—Etoposide—testicular cancer	0.000148	0.000805	CcSEcCtD
Gadoxetate—Connective tissue disorder—Doxorubicin—testicular cancer	0.000148	0.000805	CcSEcCtD
Gadoxetate—Angiopathy—Epirubicin—testicular cancer	0.000148	0.000803	CcSEcCtD
Gadoxetate—Immune system disorder—Epirubicin—testicular cancer	0.000147	0.0008	CcSEcCtD
Gadoxetate—Mediastinal disorder—Epirubicin—testicular cancer	0.000147	0.000798	CcSEcCtD
Gadoxetate—Back pain—Methotrexate—testicular cancer	0.000147	0.000797	CcSEcCtD
Gadoxetate—Chills—Epirubicin—testicular cancer	0.000146	0.000794	CcSEcCtD
Gadoxetate—Pruritus—Etoposide—testicular cancer	0.000146	0.000794	CcSEcCtD
Gadoxetate—Arrhythmia—Epirubicin—testicular cancer	0.000146	0.000791	CcSEcCtD
Gadoxetate—Vomiting—Cisplatin—testicular cancer	0.000144	0.000779	CcSEcCtD
Gadoxetate—Vision blurred—Methotrexate—testicular cancer	0.000143	0.000776	CcSEcCtD
Gadoxetate—Rash—Cisplatin—testicular cancer	0.000142	0.000772	CcSEcCtD
Gadoxetate—Dermatitis—Cisplatin—testicular cancer	0.000142	0.000772	CcSEcCtD
Gadoxetate—Diarrhoea—Etoposide—testicular cancer	0.000142	0.000768	CcSEcCtD
Gadoxetate—Ill-defined disorder—Methotrexate—testicular cancer	0.000141	0.000764	CcSEcCtD
Gadoxetate—Flushing—Doxorubicin—testicular cancer	0.00014	0.00076	CcSEcCtD
Gadoxetate—Cardiac disorder—Doxorubicin—testicular cancer	0.00014	0.00076	CcSEcCtD
Gadoxetate—Flatulence—Epirubicin—testicular cancer	0.00014	0.00076	CcSEcCtD
Gadoxetate—Dysgeusia—Epirubicin—testicular cancer	0.000139	0.000755	CcSEcCtD
Gadoxetate—Back pain—Epirubicin—testicular cancer	0.000137	0.000746	CcSEcCtD
Gadoxetate—Angiopathy—Doxorubicin—testicular cancer	0.000137	0.000743	CcSEcCtD
Gadoxetate—Malaise—Methotrexate—testicular cancer	0.000137	0.000743	CcSEcCtD
Gadoxetate—Dizziness—Etoposide—testicular cancer	0.000137	0.000742	CcSEcCtD
Gadoxetate—Immune system disorder—Doxorubicin—testicular cancer	0.000136	0.00074	CcSEcCtD
Gadoxetate—Vertigo—Methotrexate—testicular cancer	0.000136	0.00074	CcSEcCtD
Gadoxetate—Mediastinal disorder—Doxorubicin—testicular cancer	0.000136	0.000738	CcSEcCtD
Gadoxetate—Chills—Doxorubicin—testicular cancer	0.000136	0.000735	CcSEcCtD
Gadoxetate—Arrhythmia—Doxorubicin—testicular cancer	0.000135	0.000732	CcSEcCtD
Gadoxetate—Nausea—Cisplatin—testicular cancer	0.000134	0.000728	CcSEcCtD
Gadoxetate—Vision blurred—Epirubicin—testicular cancer	0.000134	0.000726	CcSEcCtD
Gadoxetate—Cough—Methotrexate—testicular cancer	0.000132	0.000719	CcSEcCtD
Gadoxetate—Ill-defined disorder—Epirubicin—testicular cancer	0.000132	0.000715	CcSEcCtD
Gadoxetate—Convulsion—Methotrexate—testicular cancer	0.000132	0.000714	CcSEcCtD
Gadoxetate—Vomiting—Etoposide—testicular cancer	0.000132	0.000714	CcSEcCtD
Gadoxetate—Agitation—Epirubicin—testicular cancer	0.000131	0.000708	CcSEcCtD
Gadoxetate—Rash—Etoposide—testicular cancer	0.00013	0.000708	CcSEcCtD
Gadoxetate—Dermatitis—Etoposide—testicular cancer	0.00013	0.000707	CcSEcCtD
Gadoxetate—Headache—Etoposide—testicular cancer	0.00013	0.000703	CcSEcCtD
Gadoxetate—Flatulence—Doxorubicin—testicular cancer	0.00013	0.000703	CcSEcCtD
Gadoxetate—Chest pain—Methotrexate—testicular cancer	0.000129	0.000701	CcSEcCtD
Gadoxetate—Dysgeusia—Doxorubicin—testicular cancer	0.000129	0.000698	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000128	0.000696	CcSEcCtD
Gadoxetate—Malaise—Epirubicin—testicular cancer	0.000128	0.000695	CcSEcCtD
Gadoxetate—Discomfort—Methotrexate—testicular cancer	0.000128	0.000693	CcSEcCtD
Gadoxetate—Vertigo—Epirubicin—testicular cancer	0.000128	0.000692	CcSEcCtD
Gadoxetate—Syncope—Epirubicin—testicular cancer	0.000127	0.000691	CcSEcCtD
Gadoxetate—Back pain—Doxorubicin—testicular cancer	0.000127	0.00069	CcSEcCtD
Gadoxetate—Palpitations—Epirubicin—testicular cancer	0.000126	0.000681	CcSEcCtD
Gadoxetate—Loss of consciousness—Epirubicin—testicular cancer	0.000125	0.000677	CcSEcCtD
Gadoxetate—Cough—Epirubicin—testicular cancer	0.000124	0.000673	CcSEcCtD
Gadoxetate—Anaphylactic shock—Methotrexate—testicular cancer	0.000124	0.000672	CcSEcCtD
Gadoxetate—Vision blurred—Doxorubicin—testicular cancer	0.000124	0.000672	CcSEcCtD
Gadoxetate—Convulsion—Epirubicin—testicular cancer	0.000123	0.000668	CcSEcCtD
Gadoxetate—Infection—Methotrexate—testicular cancer	0.000123	0.000668	CcSEcCtD
Gadoxetate—Nausea—Etoposide—testicular cancer	0.000123	0.000667	CcSEcCtD
Gadoxetate—Ill-defined disorder—Doxorubicin—testicular cancer	0.000122	0.000662	CcSEcCtD
Gadoxetate—Nervous system disorder—Methotrexate—testicular cancer	0.000122	0.000659	CcSEcCtD
Gadoxetate—Chest pain—Epirubicin—testicular cancer	0.000121	0.000656	CcSEcCtD
Gadoxetate—Agitation—Doxorubicin—testicular cancer	0.000121	0.000655	CcSEcCtD
Gadoxetate—Anxiety—Epirubicin—testicular cancer	0.000121	0.000654	CcSEcCtD
Gadoxetate—Skin disorder—Methotrexate—testicular cancer	0.00012	0.000653	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00012	0.000652	CcSEcCtD
Gadoxetate—Hyperhidrosis—Methotrexate—testicular cancer	0.00012	0.00065	CcSEcCtD
Gadoxetate—Discomfort—Epirubicin—testicular cancer	0.00012	0.000648	CcSEcCtD
Gadoxetate—Malaise—Doxorubicin—testicular cancer	0.000119	0.000643	CcSEcCtD
Gadoxetate—Dry mouth—Epirubicin—testicular cancer	0.000118	0.000642	CcSEcCtD
Gadoxetate—Vertigo—Doxorubicin—testicular cancer	0.000118	0.000641	CcSEcCtD
Gadoxetate—Anorexia—Methotrexate—testicular cancer	0.000118	0.000641	CcSEcCtD
Gadoxetate—Syncope—Doxorubicin—testicular cancer	0.000118	0.00064	CcSEcCtD
Gadoxetate—Palpitations—Doxorubicin—testicular cancer	0.000116	0.00063	CcSEcCtD
Gadoxetate—Oedema—Epirubicin—testicular cancer	0.000116	0.000629	CcSEcCtD
Gadoxetate—Anaphylactic shock—Epirubicin—testicular cancer	0.000116	0.000629	CcSEcCtD
Gadoxetate—Hypotension—Methotrexate—testicular cancer	0.000116	0.000628	CcSEcCtD
Gadoxetate—Loss of consciousness—Doxorubicin—testicular cancer	0.000116	0.000627	CcSEcCtD
Gadoxetate—Infection—Epirubicin—testicular cancer	0.000115	0.000625	CcSEcCtD
Gadoxetate—Cough—Doxorubicin—testicular cancer	0.000115	0.000622	CcSEcCtD
Gadoxetate—Shock—Epirubicin—testicular cancer	0.000114	0.000619	CcSEcCtD
Gadoxetate—Convulsion—Doxorubicin—testicular cancer	0.000114	0.000618	CcSEcCtD
Gadoxetate—Nervous system disorder—Epirubicin—testicular cancer	0.000114	0.000617	CcSEcCtD
Gadoxetate—Tachycardia—Epirubicin—testicular cancer	0.000113	0.000614	CcSEcCtD
Gadoxetate—Skin disorder—Epirubicin—testicular cancer	0.000113	0.000611	CcSEcCtD
Gadoxetate—Hyperhidrosis—Epirubicin—testicular cancer	0.000112	0.000608	CcSEcCtD
Gadoxetate—Chest pain—Doxorubicin—testicular cancer	0.000112	0.000607	CcSEcCtD
Gadoxetate—Anxiety—Doxorubicin—testicular cancer	0.000112	0.000605	CcSEcCtD
Gadoxetate—Paraesthesia—Methotrexate—testicular cancer	0.000111	0.000604	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000111	0.000603	CcSEcCtD
Gadoxetate—Discomfort—Doxorubicin—testicular cancer	0.000111	0.0006	CcSEcCtD
Gadoxetate—Anorexia—Epirubicin—testicular cancer	0.000111	0.0006	CcSEcCtD
Gadoxetate—Dyspnoea—Methotrexate—testicular cancer	0.00011	0.000599	CcSEcCtD
Gadoxetate—Dry mouth—Doxorubicin—testicular cancer	0.000109	0.000594	CcSEcCtD
Gadoxetate—Hypotension—Epirubicin—testicular cancer	0.000108	0.000588	CcSEcCtD
Gadoxetate—Decreased appetite—Methotrexate—testicular cancer	0.000108	0.000584	CcSEcCtD
Gadoxetate—Anaphylactic shock—Doxorubicin—testicular cancer	0.000107	0.000582	CcSEcCtD
Gadoxetate—Oedema—Doxorubicin—testicular cancer	0.000107	0.000582	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000107	0.00058	CcSEcCtD
Gadoxetate—Fatigue—Methotrexate—testicular cancer	0.000107	0.00058	CcSEcCtD
Gadoxetate—Infection—Doxorubicin—testicular cancer	0.000107	0.000578	CcSEcCtD
Gadoxetate—Shock—Doxorubicin—testicular cancer	0.000106	0.000573	CcSEcCtD
Gadoxetate—Nervous system disorder—Doxorubicin—testicular cancer	0.000105	0.000571	CcSEcCtD
Gadoxetate—Tachycardia—Doxorubicin—testicular cancer	0.000105	0.000568	CcSEcCtD
Gadoxetate—Skin disorder—Doxorubicin—testicular cancer	0.000104	0.000565	CcSEcCtD
Gadoxetate—Paraesthesia—Epirubicin—testicular cancer	0.000104	0.000565	CcSEcCtD
Gadoxetate—Hyperhidrosis—Doxorubicin—testicular cancer	0.000104	0.000563	CcSEcCtD
Gadoxetate—Dyspnoea—Epirubicin—testicular cancer	0.000103	0.000561	CcSEcCtD
Gadoxetate—Anorexia—Doxorubicin—testicular cancer	0.000102	0.000555	CcSEcCtD
Gadoxetate—Feeling abnormal—Methotrexate—testicular cancer	0.000102	0.000554	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Methotrexate—testicular cancer	0.000101	0.00055	CcSEcCtD
Gadoxetate—Decreased appetite—Epirubicin—testicular cancer	0.000101	0.000547	CcSEcCtD
Gadoxetate—Hypotension—Doxorubicin—testicular cancer	0.0001	0.000544	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Epirubicin—testicular cancer	0.0001	0.000543	CcSEcCtD
Gadoxetate—Fatigue—Epirubicin—testicular cancer	0.0001	0.000542	CcSEcCtD
Gadoxetate—Constipation—Epirubicin—testicular cancer	9.92e-05	0.000538	CcSEcCtD
Gadoxetate—Urticaria—Methotrexate—testicular cancer	9.84e-05	0.000534	CcSEcCtD
Gadoxetate—Abdominal pain—Methotrexate—testicular cancer	9.8e-05	0.000531	CcSEcCtD
Gadoxetate—Body temperature increased—Methotrexate—testicular cancer	9.8e-05	0.000531	CcSEcCtD
Gadoxetate—Paraesthesia—Doxorubicin—testicular cancer	9.63e-05	0.000523	CcSEcCtD
Gadoxetate—Dyspnoea—Doxorubicin—testicular cancer	9.57e-05	0.000519	CcSEcCtD
Gadoxetate—Feeling abnormal—Epirubicin—testicular cancer	9.56e-05	0.000518	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Epirubicin—testicular cancer	9.48e-05	0.000514	CcSEcCtD
Gadoxetate—Decreased appetite—Doxorubicin—testicular cancer	9.33e-05	0.000506	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Doxorubicin—testicular cancer	9.26e-05	0.000502	CcSEcCtD
Gadoxetate—Fatigue—Doxorubicin—testicular cancer	9.25e-05	0.000502	CcSEcCtD
Gadoxetate—Urticaria—Epirubicin—testicular cancer	9.21e-05	0.0005	CcSEcCtD
Gadoxetate—Constipation—Doxorubicin—testicular cancer	9.18e-05	0.000498	CcSEcCtD
Gadoxetate—Body temperature increased—Epirubicin—testicular cancer	9.17e-05	0.000497	CcSEcCtD
Gadoxetate—Abdominal pain—Epirubicin—testicular cancer	9.17e-05	0.000497	CcSEcCtD
Gadoxetate—Hypersensitivity—Methotrexate—testicular cancer	9.13e-05	0.000495	CcSEcCtD
Gadoxetate—Asthenia—Methotrexate—testicular cancer	8.89e-05	0.000482	CcSEcCtD
Gadoxetate—Feeling abnormal—Doxorubicin—testicular cancer	8.84e-05	0.00048	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Doxorubicin—testicular cancer	8.77e-05	0.000476	CcSEcCtD
Gadoxetate—Pruritus—Methotrexate—testicular cancer	8.77e-05	0.000476	CcSEcCtD
Gadoxetate—Hypersensitivity—Epirubicin—testicular cancer	8.54e-05	0.000463	CcSEcCtD
Gadoxetate—Urticaria—Doxorubicin—testicular cancer	8.52e-05	0.000462	CcSEcCtD
Gadoxetate—Abdominal pain—Doxorubicin—testicular cancer	8.48e-05	0.00046	CcSEcCtD
Gadoxetate—Body temperature increased—Doxorubicin—testicular cancer	8.48e-05	0.00046	CcSEcCtD
Gadoxetate—Diarrhoea—Methotrexate—testicular cancer	8.48e-05	0.00046	CcSEcCtD
Gadoxetate—Asthenia—Epirubicin—testicular cancer	8.32e-05	0.000451	CcSEcCtD
Gadoxetate—Pruritus—Epirubicin—testicular cancer	8.2e-05	0.000445	CcSEcCtD
Gadoxetate—Dizziness—Methotrexate—testicular cancer	8.19e-05	0.000444	CcSEcCtD
Gadoxetate—Diarrhoea—Epirubicin—testicular cancer	7.93e-05	0.00043	CcSEcCtD
Gadoxetate—Hypersensitivity—Doxorubicin—testicular cancer	7.9e-05	0.000429	CcSEcCtD
Gadoxetate—Vomiting—Methotrexate—testicular cancer	7.88e-05	0.000427	CcSEcCtD
Gadoxetate—Rash—Methotrexate—testicular cancer	7.81e-05	0.000424	CcSEcCtD
Gadoxetate—Dermatitis—Methotrexate—testicular cancer	7.81e-05	0.000423	CcSEcCtD
Gadoxetate—Headache—Methotrexate—testicular cancer	7.76e-05	0.000421	CcSEcCtD
Gadoxetate—Asthenia—Doxorubicin—testicular cancer	7.7e-05	0.000418	CcSEcCtD
Gadoxetate—Dizziness—Epirubicin—testicular cancer	7.67e-05	0.000416	CcSEcCtD
Gadoxetate—Pruritus—Doxorubicin—testicular cancer	7.59e-05	0.000412	CcSEcCtD
Gadoxetate—Vomiting—Epirubicin—testicular cancer	7.37e-05	0.0004	CcSEcCtD
Gadoxetate—Nausea—Methotrexate—testicular cancer	7.36e-05	0.000399	CcSEcCtD
Gadoxetate—Diarrhoea—Doxorubicin—testicular cancer	7.34e-05	0.000398	CcSEcCtD
Gadoxetate—Rash—Epirubicin—testicular cancer	7.31e-05	0.000397	CcSEcCtD
Gadoxetate—Dermatitis—Epirubicin—testicular cancer	7.3e-05	0.000396	CcSEcCtD
Gadoxetate—Headache—Epirubicin—testicular cancer	7.26e-05	0.000394	CcSEcCtD
Gadoxetate—Dizziness—Doxorubicin—testicular cancer	7.1e-05	0.000385	CcSEcCtD
Gadoxetate—Nausea—Epirubicin—testicular cancer	6.89e-05	0.000374	CcSEcCtD
Gadoxetate—Vomiting—Doxorubicin—testicular cancer	6.82e-05	0.00037	CcSEcCtD
Gadoxetate—Rash—Doxorubicin—testicular cancer	6.76e-05	0.000367	CcSEcCtD
Gadoxetate—Dermatitis—Doxorubicin—testicular cancer	6.76e-05	0.000367	CcSEcCtD
Gadoxetate—Headache—Doxorubicin—testicular cancer	6.72e-05	0.000365	CcSEcCtD
Gadoxetate—Nausea—Doxorubicin—testicular cancer	6.37e-05	0.000346	CcSEcCtD
